Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

NEJM evidence

Showing results (21-30 of 671) with videos related to

Pageof 68
Sort By:
NEJM Evidence|May 30, 2024
How Cluster RCTs WorkSuellen Li, C Corey Hardin, Michael Fralick, et al.
NEJM Evidence|July 23, 2024
Acute Proximal Hamstring Tear - Who Will Benefit from Surgical Intervention?Maegan Shields, Tim Dwyer
NEJM Evidence|July 23, 2024
Intensive Glucose Control in Critically Ill Patients - How Low Do We Go?Shohinee Sarma
NEJM Evidence|June 20, 2022
Harm-to-Benefit of Three Decades of Prostate Cancer Screening in Black MenSpyridon P Basourakos, Roman Gulati, Randy A Vince, et al.
NEJM Evidence|February 6, 2024
Overall Survival and Response with Nivolumab and Relatlimab in Advanced Melanoma
NEJM Evidence|November 4, 2022
Ethical Challenges to Improving Access to Human Papillomavirus Vaccines in Low- and Middle-Income CountriesAhizechukwu C Eke, Vanessa B Kerry
NEJM Evidence|September 24, 2024
Understanding Over-Treatment - Lessons from a Clinical TrialBeth Ciavaglia
NEJM Evidence|November 5, 2025
Oral Psoriasis Therapy - For Whom and at What Cost and Risk?Robert S Stern
NEJM Evidence|November 25, 2025
Minimally Invasive Pancreatoduodenectomy - Safety FirstRachel H Joung, Rebecca A Snyder
NEJM Evidence|June 23, 2025
Semaglutide for Type I Diabetes - A New Twist on an Old StoryClifford J Rosen
Pageof 68

Showing results (21-30 of 671) with videos related to

Sort By:
Pageof 68
NEJM Evidence|May 30, 2024
How Cluster RCTs WorkSuellen Li, C Corey Hardin, Michael Fralick, et al.
NEJM Evidence|July 23, 2024
Acute Proximal Hamstring Tear - Who Will Benefit from Surgical Intervention?Maegan Shields, Tim Dwyer
NEJM Evidence|July 23, 2024
Intensive Glucose Control in Critically Ill Patients - How Low Do We Go?Shohinee Sarma
NEJM Evidence|June 20, 2022
Harm-to-Benefit of Three Decades of Prostate Cancer Screening in Black MenSpyridon P Basourakos, Roman Gulati, Randy A Vince, et al.
NEJM Evidence|February 6, 2024
Overall Survival and Response with Nivolumab and Relatlimab in Advanced Melanoma
NEJM Evidence|November 4, 2022
Ethical Challenges to Improving Access to Human Papillomavirus Vaccines in Low- and Middle-Income CountriesAhizechukwu C Eke, Vanessa B Kerry
NEJM Evidence|September 24, 2024
Understanding Over-Treatment - Lessons from a Clinical TrialBeth Ciavaglia
NEJM Evidence|November 5, 2025
Oral Psoriasis Therapy - For Whom and at What Cost and Risk?Robert S Stern
NEJM Evidence|November 25, 2025
Minimally Invasive Pancreatoduodenectomy - Safety FirstRachel H Joung, Rebecca A Snyder
NEJM Evidence|June 23, 2025
Semaglutide for Type I Diabetes - A New Twist on an Old StoryClifford J Rosen
Pageof 68